By 2030, it is anticipated that the South African radiotherapy Market will reach a value of $xx Mn from $45 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in South Africa is dominated by a few domestic players such as Acceletronics, Medequip, and Oncovision. The radiotherapy market in South Africa is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for South African radiotherapy is increasing on account of the rise in cancer cases in the country.
By 2030, it is anticipated that the South African radiotherapy Market will reach a value of $xx Mn from $45 Mn in 2022, growing at a CAGR of xx% during 2022-30.
South Africa is an upper-middle-income, developing country located at the southern tip of the African continent. South Africa's healthcare system is divided into public (83%) and private (17%) sectors. South Africa is divided into nine provinces, and the prevalence of lung cancer and treatment choices vary by region. The National Cancer Registry was founded in 1986 to give statistics on cancer incidence in South Africa. The top three cancers affecting men in South Africa are prostate, colorectal, and lung, whereas the top three cancers affecting women are breast, cervical, and colorectal.
Cancer is becoming more prevalent in South Africa and worldwide. However, the global death rate is declining. When population growth and age are taken into account, the age-standardized death rate in South Africa has decreased by 15% between 1990 and 2019. South Africa's government spent 4.6% of its GDP on healthcare in 2020.
Market Growth Drivers Analysis
In comparison to patients in Nigeria and Tanzania, South Africans have much greater access to radiation. South Africa has one radiation machine for every 608,000 people. The South African National Department of Health (NDoH) published the National Cancer Strategic Framework (NCSF): 2017-2022, which outlines the country's strategy for achieving equal access to cancer services for all South Africans. Cancer, as a noncommunicable disease, contributes to South Africa's triple disease burden. The South African Oncology Consortium and the Cancer Association of South Africa are two cancer research institutions in South Africa. These aspects could boost South Africa, Radiotherapy Market.
Market restrains.
South Africa's radiation oncology facilities are generally expanding, with more radiotherapy centres and precision technology than ever before, however, there is a large regional disparity in equipment distribution. Only three of the nine provinces in the country have more than 64 of these (77%). The National Strategic Cancer Framework (2017-2022), which had lofty goals for lowering cancer prevalence rates, has fallen short of expectations. Inadequate access to radiotherapy devices has been identified as a major contributor to South Africa's disproportionately high - and rising - cancer mortality rates. Due to a variety of issues, the government's preventative, screening, and treatment methods have been limited (including the cost of infrastructure, insufficient access to medication, and weak health referral pathways). These factors may deter new entrants into the South Africa Radiotherapy Market.
Key Players
April 2023: This year's International Conference on Oncology (ICO) will be place in Cancun, Mexico. Events, meetings, seminars, congresses, workshops, summits, and symposiums are open to researchers, scientists, academics, engineers, academic, scientific, and university practitioners.
October 2022: The Ethos radiotherapy system was launched today by the Life Oncology unit at Life Vincent Pallotti Hospital, a revolutionary new technology, the first in Sub-Saharan Africa, that uses artificial intelligence (AI) and adaptive treatment to adjust cancer treatments in response to patients' unique, changing needs.
In South Africa, the regulations and reimbursement of radiotherapy are overseen by the South African Health Products Regulatory Authority (SAHPRA) and the Medical Schemes Act. SAHPRA is responsible for regulating the use of radiation in South Africa, including the use of radiotherapy. The South African Society of Clinical and Radiation Oncology (SASCRO) is the main professional organization for radiation oncologists in South Africa and works closely with SAHPRA to develop guidelines and standards of practice for radiotherapy. The Medical Schemes Act is responsible for regulating the medical schemes industry in South Africa, including reimbursement for radiotherapy services.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Type (Revenue, USD Billion):
?By Technology (Revenue, USD Billion):
By Application (Revenue, USD Billion):
By End User (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.